Your session is about to expire
← Back to Search
Cardiac Rehabilitation for Atrial Fibrillation
N/A
Waitlist Available
Research Sponsored by MultiCare Health System Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Documented diagnosis of Paroxysmal and persistent Atrial Fibrillation
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after the first intake appointment
Awards & highlights
Study Summary
This trial will test whether an exercise-based cardiac rehabilitation intervention can reduce the risk of AF returning after an ablation procedure.
Who is the study for?
This trial is for adults over 18 with Paroxysmal and persistent Atrial Fibrillation who've had an ablation procedure at least 2 weeks ago. Participants must be able to attend a cardiac rehab program thrice weekly for 12 weeks, follow medication therapy, and have no physical limitations or severe cognitive impairments that prevent exercise.Check my eligibility
What is being tested?
The study tests if a supervised 12-week exercise-based cardiac rehabilitation program can reduce the recurrence of atrial fibrillation after an ablation procedure. Patients are randomly assigned to either this intervention group or a control group receiving usual care.See study design
What are the potential side effects?
While not explicitly listed, potential side effects may include typical risks associated with exercise such as muscle strains, fatigue, shortness of breath during activity, and in rare cases, heart-related events especially given the patient population's underlying condition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Atrial Fibrillation that comes and goes or stays.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months after the first intake appointment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after the first intake appointment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in 40 patients at six- and twelve-months post-ablation procedure.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: cardiac rehabilitation intervention groupExperimental Treatment1 Intervention
Participants assigned to the intervention group will participate in pre-post assessments and a 12-week supervised exercise based cardiac rehabilitation program at a designated local Pulse Heart Institute Cardiac Rehabilitation program.
Group II: control groupActive Control1 Intervention
Participants assigned to the control group will participate in pre-post assessments and will maintain usual care and current activity levels.
Find a Location
Who is running the clinical trial?
MultiCare Health System Research InstituteLead Sponsor
12 Previous Clinical Trials
986 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a procedure to isolate the posterior wall of my heart.I can attend 36 cardiac rehab sessions over 12 weeks if required.I have an active email and phone number.I cannot do rehab exercises because of my physical condition.I have been diagnosed with dementia or have cognitive issues.I can go to two clinic visits at the specified cardiac rehab program.I follow my prescribed medication routine, including heart rate and blood thinner meds.I have been diagnosed with Atrial Fibrillation that comes and goes or stays.I am 18 years old or older.I do not speak English.I have heart or lung disease that qualifies me for a rehabilitation program.I have had more than one ablation procedure.I have had atrial fibrillation for a long time.I had ablation treatment and it's been at least 2 weeks since.
Research Study Groups:
This trial has the following groups:- Group 1: control group
- Group 2: cardiac rehabilitation intervention group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the ultimate capacity of participants for this experiment?
"Affirmative. The medical trial's information on clinicaltrials.gov reveals that it is actively enlisting patients since its debut on June 30th 2022 and last update of July 6th, with a quota of 40 participants from one centre."
Answered by AI
Are there any current vacancies in this research endeavor?
"Per the clinicaltrials.gov listings, this research study is open for patient enrollment and was initially posted on June 30th 2022 with its most recent update occurring 6 days later."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger